Protective effect of oleuropein on ketamine-induced cardiotoxicity in rats
dc.authorid | COMEZ, MEHMET/0000-0003-0821-5148 | |
dc.authorid | AYDIN, TUBA/0000-0002-7653-6480 | |
dc.authorid | Ozkan, Huseyin/0000-0001-5753-8985 | |
dc.authorid | GOKCEK, ISHAK/0000-0002-0590-6405 | |
dc.authorid | GUVENC, MEHMET/0000-0002-9716-0697 | |
dc.contributor.author | Comez, Mehmet Selim | |
dc.contributor.author | Cellat, Mustafa | |
dc.contributor.author | Ozkan, Huseyin | |
dc.contributor.author | Borazan, Yakup | |
dc.contributor.author | Aydin, Tuba | |
dc.contributor.author | Gokcek, Ishak | |
dc.contributor.author | Turk, Erdinc | |
dc.date.accessioned | 2024-09-18T20:28:15Z | |
dc.date.available | 2024-09-18T20:28:15Z | |
dc.date.issued | 2020 | |
dc.department | Hatay Mustafa Kemal Üniversitesi | en_US |
dc.description.abstract | The antioxidant and cardioprotective effects of oleuropein have been reported in several studies; however, its effect on ketamine cardiotoxicity has not been known yet. The aim of this study was to investigate the effects of oleuropein in ketamine-induced cardiotoxicity model in rats. A total of 28 male Wistar Albino rats were included in the study and they were randomly divided into four groups, each having seven rats. Group 1 (control): rats were given 1 mL of DMSO by oral gavage method for 7 days. Group 2 (ketamine): on the seventh day of the study, 60 mg/kg ketamine was administered intraperitoneally. Then, 60 mg/kg ketamine was administered intraperitoneally every 10 min for 3 h. Group 3 (oleuropein): rats were given 200 mg/kg/day oleuropein by oral gavage method for 7 days. Group 4 (oleuropein + ketamine): rats were given 1 x 200 mg/kg oleuropein by oral gavage method for 7 days. Furthermore, 60 mg/kg ketamine was administered intraperitoneally on the seventh day of the experiment. Then, 60 mg/kg ketamine was administered intraperitoneally every 10 min for 3 h. Serum cardiac marker (TnI, CK-MB and CK) levels were measured. Histopathological analysis was performed on a portion of the cardiac tissue. Cardiac tissue oxidative stress and antioxidant markers (MDA, GSH, GSH.Px and CAT), TNF-alpha, IL-6, NF-kappa B, COX-2 and Nrf-2 gene expressions, and protein conversion levels of related genes were determined. Data obtained showed that ketamine administration increased MDA (p < 0.001), TNF-alpha (p < 0.01), IL-6 (p < 0.01), COX-2 (p < 0.001) and NF-kappa B (p < 0.001) levels, as well as serum TnI (p < 0.001), CK-MB (p < 0.001) and CK (p < 0.01) levels whereas decreased GSH (p < 0.05) and Nrf-2 (p < 0.05) levels, as well as GSH-Px (p < 0.001) and CAT (p < 0.05) enzyme activities. Oleuropein administration was observed to decrease MDA, TNF-alpha, IL-6, COX-2, NF-kappa B, TnI, CK-MB and CK levels close to the control group and to increase GSH levels and GSH-Px and CAT enzyme activities close to the control group. This study showed that oleuropein administration reversed the increased oxidative stress and inflammation as a result of the use of ketamine and had protective effects on the heart. | en_US |
dc.description.sponsorship | Scientific Research Project Coordination of the Hatay Mustafa Kemal University, Turkey [18.M.062/2018] | en_US |
dc.description.sponsorship | This study funded by the Scientific Research Project Coordination of the Hatay Mustafa Kemal University, Turkey (No: 18.M.062/2018). | en_US |
dc.identifier.doi | 10.1007/s00210-020-01870-w | |
dc.identifier.endpage | 1699 | en_US |
dc.identifier.issn | 0028-1298 | |
dc.identifier.issn | 1432-1912 | |
dc.identifier.issue | 9 | en_US |
dc.identifier.pmid | 32383030 | en_US |
dc.identifier.scopus | 2-s2.0-85084315429 | en_US |
dc.identifier.scopusquality | Q2 | en_US |
dc.identifier.startpage | 1691 | en_US |
dc.identifier.uri | https://doi.org/10.1007/s00210-020-01870-w | |
dc.identifier.uri | https://hdl.handle.net/20.500.12483/10811 | |
dc.identifier.volume | 393 | en_US |
dc.identifier.wos | WOS:000531398000003 | en_US |
dc.identifier.wosquality | Q3 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.indekslendigikaynak | PubMed | en_US |
dc.language.iso | en | en_US |
dc.publisher | Springer | en_US |
dc.relation.ispartof | Naunyn-Schmiedebergs Archives of Pharmacology | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Ketamine | en_US |
dc.subject | Oleuropein | en_US |
dc.subject | Cardiotoxicity | en_US |
dc.title | Protective effect of oleuropein on ketamine-induced cardiotoxicity in rats | en_US |
dc.type | Article | en_US |
Dosyalar
Orijinal paket
1 - 1 / 1